SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Bill Coenen who wrote (10782)11/4/1998 10:43:00 PM
From: DELT1970  Read Replies (1) | Respond to of 14328
 
These earnings comparables will look awfully good in 1999 if analysts are correct and the market is weak, impacted by poor quarterly comparisons and ebbing momentum. Accelerating momentum will command market premium.



To: Bill Coenen who wrote (10782)11/4/1998 10:44:00 PM
From: AgAuUSA  Respond to of 14328
 
Bill,

CC should be most interesting.

1) I believe the insiders have only afew days after these earnings to buy in the open market. This may come up tomorrow. I encourage anyone who reads this to ask about it at the CC.

2) Forward looking earnings projections will be most enlightening. I would expect somewhere in the 0.14 to 0.18 range for 99.

3) I would like a breakdown on status of the UniGold products awaiting FDA approval: HIV and Strep.

4) An update on the number of employees.

5) An update on analyst/broker coverage of Triby.

6) Status of listing Triby stock in Ireland Stock Exchange.

Good luck to all!!